ClinicalTrials.govpublic full text
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
diffuse large b-cell lymphoma (dlbcl), follicular lymphoma grade iii (fl iii°), mantle cell lymphoma (mcl), blastoid variant, burkitt lymphoma (bl), aggressive marginal zone lymphoma (mzl)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 152411
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.